Serbia's Medicine Market Tops 2.2 Billion Euros
Sales of medicines and medical devices come to more than 300 euros per resident, and prescription drugs grew 15 percent. The medicines agency warns of counterfeits.

Sales of medicines and medical devices in Serbia last year topped 2.2 billion euros, which works out to more than 300 euros per resident. The total does not include supplements that people buy on their own. The figures were presented in a report by Radio Television of Serbia, with statements from the Medicines and Medical Devices Agency and from the pharmaceutical industry.
What grew the most in medicine sales?
Prescription medicines grew fastest, with an increase of 15 percent. The growth came mainly from therapies for cancer patients, for diseases of the nervous system and for metabolic diseases.
There are currently 5,146 medicines registered in Serbia, according to the Medicines and Medical Devices Agency. They include some of the newest and most expensive therapies, and the aim is to get more drugs for rare diseases onto the reimbursement list as soon as possible. Pavle Zelic of the Agency says patients benefit as a result:
“Pharmaceutical companies are now coming to Serbia, our patients are getting the latest therapy, and they have a chance to take part in clinical trials. We must not forget that either. Some 349 clinical trials of human medicines are currently being conducted in Serbia”
According to Zelic, 349 clinical trials of human medicines are under way in Serbia at the moment.
How much does the pharmaceutical industry invest and export?
According to the Serbian Chamber of Commerce, about 80 percent of pharmaceutical companies’ investment goes into equipment, and almost 90 percent of the companies say they finance themselves from their own funds. Peter Goldschmit, chief executive of the Stada group, says the group has invested hundreds of millions of euros over the past few years and has just won new approval for Vrsac:
“We have truly invested hundreds of millions over the past few years, and we have just received approval from the Stada Global Executive Board to invest another 20 million euros in Vrsac. That will let us increase production and build new capacity, and I think it shows our commitment to the future”
The new 20 million euros is earmarked for expanding production and building new capacity in Vrsac. Goldschmit also commented on the quality of domestic production:
“In Serbia we do not manufacture only to a quality that is good enough for Germany, which has the highest quality standards. Everything we make here meets European Union standards”
Makers of pharmaceutical products and preparations are big importers because they depend on raw materials, but they are also big exporters. Exports last year came to almost a billion euros, 30.2 percent more than a year earlier. Pharmaceutical products made up 2.8 percent of Serbia’s total exports. Medicines from Vrsac alone reach more than 100 countries.
What does the Medicines Agency say about counterfeits?
The World Health Organization calls counterfeit medicines a global problem: that black market turns over about 460 billion dollars a year. Zelic lists what has turned up in such preparations: rat poison, antifreeze, brick dust and road paint. These substances are used to make a tablet look genuine, even though it contains no active ingredient:
“All the things counterfeiters used to imitate the look of a tablet, but of course there is no active substance in it at all, and for patients for whom it was the last straw and the chance to survive, it can be a death sentence”
A counterfeit “Ozempic” has been found in Serbia, along with more than 3,000 ads offering supplements that promise miracles. The report does not say when the counterfeit was found or who found it. According to the figures it presents, there are fewer such ads than a few years ago.
The Agency therefore urges people not to buy medicines online or through social media, saying this is the best prevention.



